Do you have 15 minutes?
OK, great; let’s get a strong start in oligonucleotide manufacturing!
It's time for you to get into the oligo business. Investment is fueling rapid growth of the oligonucleotide therapeutics, with hundreds of companies assessing preclinical therapies. This fast growth is igniting urgency in companies to secure stable supplies of oligonucleotide active pharmaceutical ingredients (API) in preparation for drug approval.
In this video, we will look at key considerations for therapeutic developers entering this market, such as scalability, flexibility, regulatory concerns, insource/outsource considerations, and security of supply.
Watch this short, but very useful 15-minute video to learn about:
- the oligonucleotide therapeutic market
- the therapeutics in development
- challenges you may face and key considerations to address those challenges
- how to scale up manufacturing
About the presenter
Lucy Cook - Global Marketing Manager for Nucleic Acid Therapeutics - Cytiva
Lucy has more than twenty years of experience in the life sciences industry in both sales and marketing across various industry segments. Most recently, Lucy has become fascinated with nucleic acid therapeutics and the huge promise of mRNA and oligonucleotides. She is dedicated to supporting manufacturers bringing nucleic acid-based therapeutics to the market.
Fill out the form to access the video
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante.
Acrodisc® Syringe Filters
Reliable Results with Superior Protection
Form title
Form sub title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante.
Panel 2 header
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Repellendus aliquid tempore natus voluptates repudiandae, eos dolorem libero inventore, quod incidunt, asperiores. Reiciendis itaque enim pariatur, blanditiis minima autem quo a nulla, obcaecati quis, excepturi atque ab rerum! Sequi molestias vel eum, hic, perspiciatis eius suscipit reprehenderit molestiae vitae similique.
Panel 3 header
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Repellendus aliquid tempore natus voluptates repudiandae, eos dolorem libero inventore, quod incidunt, asperiores. Reiciendis itaque enim pariatur, blanditiis minima autem quo a nulla, obcaecati quis, excepturi atque ab rerum! Sequi molestias vel eum, hic, perspiciatis eius suscipit reprehenderit molestiae vitae similique.
Follow our connected mAb perfusion process
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even slightly believable. If you are going to use a passage of Lorem Ipsum, you need to be sure there isn't anything embarrassing hidden in the middle of text.
All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making this the first true generator on the Internet. It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable. The generated Lorem Ipsum is therefore always free from repetition, injected humour, or non-characteristic words etc.
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .
Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .